Takecab Tablets 20mg : Takeda Pharmaceutical Company …
Certificate of Origin (CoO), Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) of “Takecab Tablets 20mg” are available. *PIL and SmPC are written in Japanese.
医療用医薬品 : タケキャブ (タケキャブ錠10mg 他) - KEGG
2024年11月20日 · 動物試験（ラット）において、最大臨床用量（40mg/日）におけるボノプラザンの曝露量（AUC）の約28倍を超える曝露量で、胎児体重及び胎盤重量の低値、外表異常（肛門狭窄及び尾の異常）、並びに内臓異常（膜性部心室中隔欠損及び鎖骨下動脈起始異常）が認められている。 治療上の有益性及び母乳栄養の有益性を考慮し、授乳の継続又は中止を検討すること。
The First-in-Class Potassium-Competitive Acid Blocker ... - PubMed
Vonoprazan fumarate (Takecab) is a first-in-class potassium-competitive acid blocker that has been available in the market in Japan since February 2015.
Vonoprazan Tablets SMPC
This document provides information on Takecab tablets, including 10mg and 20mg formulations. It describes the drug's approval information, composition, efficacy for treating various conditions like gastric ulcers and helping eradicate Helicobacter pylori infections.
Takecab tablets 10 mg for ulcer and reflux esophagitis …
Indicated for a range of conditions including gastric and duodenal ulcers, as well as reflux esophagitis, Takecab tablets offer efficacious therapy. Particularly noteworthy is their capacity to prevent the recurrence of gastric and duodenal ulcers induced by low-dose aspirins or other nonsteroidal anti-inflammatory drugs.
Takecab Tablets 20mg [agents for killing Helicobacter
2020年1月10日 · Takecab Tablets 20mg [agents for killing Helicobacter pylori] (タケキャブ錠20mg[ヘリコバクター・ピロリ除菌]) - Vonoprazan fumarate faint red oval tablet, major axis: 11.2 mm,
Takecab Tablets 10mg [agents for digestive organ] | myHealthbox
BRAND NAME: TAKECAB TABLETS 10MG [AGENTS FOR DIGESTIVE ORGAN] ACTIVE INGREDIENT: Vonoprazan fumarate DOSAGE FORM: faint yellow oval tablet, major axis: 8.2 mm, minor axis: 4.7 mm, thickness: 3.4 mm IMPRINT OR PRINT ON WRAPPING: (Face)タケキャブ 10mg, (Back)タケキャブ 10 EFFECTS OF THIS MEDICINE This …
Takecab Tablets 10mg [agents for killing Helicobacter
BRAND NAME: TAKECAB TABLETS 10MG [AGENTS FOR KILLING HELICOBACTER PYLORI] ACTIVE INGREDIENT: Vonoprazan fumarate DOSAGE FORM: faint yellow oval tablet, major axis: 8.2 mm, minor axis: 4.7 mm, thickness: 3.4 mm IMPRINT OR PRINT ON WRAPPING: (Face)タケキャブ 10mg, (Back)タケキャブ 10 EFFECTS OF …
Takecab: Uses, Side Effects, and Warnings - Med Review Hub
2023年6月23日 · Takecab is the brand name for a drug called vonoprazan, which belongs to a class of medications known as proton pump inhibitors. It is commonly used to treat gastroesophageal reflux disease (GERD), heartburn, and other conditions related to excessive stomach acid production.
每日一药||Vonoprazan fumarate/Takecab® - 雪球
2018年5月18日 · Takecab®被批准用于治疗胃溃疡、十二指肠溃疡和反流性食道炎，预防长期低剂量使用阿司匹林或非甾体抗炎药导致的胃溃疡和十二指肠溃疡复发，辅助根除幽门螺杆菌。 Takecab®是口服片剂，每片含有10 mg/20 mg Vonoprazan。 推荐剂量成人每日1次，每次20 mg,。 结构式. 作用机制. Vonoprazan fumarate是一种新型的钾离子竞争性酸阻滞剂 (P-CAB)，可以在不依赖酸性环境的情况下，抑制K+与质子泵的结合，从而迅速、强效、持久的抑制胃壁 …